Table 4 A review of the performance of some nanocomposite adsorbent materials used to remove drug from water.
Adsorbent nanomaterials | Adsorbate | Optimum adsorption condition | Adsorbate initial concentration (mg L−1) | Maximum adsorption capacity (mg g−1) | Reusability cycles/removal% after last cycle | References |
|---|---|---|---|---|---|---|
Artich-Bch-NaOH | Metformin hydrochloride (MFH) | Acidic medium, 45 min | 10 | ~ 17 | 5 cycles, 78.5% | |
NBent-NTiO2-Chit nanocomposite | Levofloxacin (LEVO) Ceftriaxone (CFT) | pH4, 10 min pH5, 10 min | 5 | ~ 43 ~ 36 | 3 cycles, 95% 3 cycles, 92.8% | |
NFe3O4@Zn(GA)/Starch-Hydrogel | Fluvastatin (FLV) | pH2, 30 min | 40 | ~ 782 | 5 cycles, 700 mg g−1 | |
V2O5@Ch/Cu-TMA nanobiosorbent | levofloxacin (LEVO) | pH3, 30 min | 10 | ~ 9 | 4 cycles, 84.35% | |
Fe3O4–MoO3-AC | Ciprofloxacin (CPF) | pH7, 30 min | 10 | ~ 19 | 5 cycles, 90.5% | |
SPVA/IC/SZrO2-2.5 nanocompoaite | Cefotaxime | pH6, 3 h | 100 | ~ 475 | 10 cycles, 91% | This work |